spacer
home >
PUBLICATIONS

 
 
 
Featured in this issue

The Elephant in the Room

Kurt Mussina at Frenova Renal Research

Systematic and concrete marketing activities are an often overlooked aspect of a successful clinical research business.

 


Maintaining Control

Anna Lukyanova at Arriello

Pharma and biotech companies should take care not to neglect the role of formal project management in process outsourcing.
 
Paving the Way

Rik Van Mol at Veeva Systems

In order to drive efficiency and a faster time to market, sponsors, CROs, and pharma companies need to embrace collaboration.

spacer

 

 
News and Press Releases

Tagrisso approved in the US for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer

AstraZeneca’s Tagrisso (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumour resection with curative intent. Tagrisso is indicated for EGFRm patients whose tumours have exon 19 deletions or exon 21 L858R mutations as detected by an approved test.
More info >>

 
White Papers

Data Technology as a Catalyst for Growth in the Life Sciences

AIGENPULSE

The life sciences industry is changing at a rapid pace. The need to develop the next blockbuster is pushing current technologies and methodologies to the limit. Scientific advancement over the last decades was embossed with giant leaps in knowledge, however, the new reality is that smaller incremental gains need to be carved out with ever increasing investments. In order to survive, progress and prosper in this new reality, a holistic approach to getting the most of research data is crucial. In fact, it will likely be the difference of being in existence in 5-10 years or not. For those bold enough to step into an area they are unfamiliar with, huge rewards are waiting.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement